Literature DB >> 21972180

Organotypic slice culture from human adult ventricular myocardium.

Matthias Brandenburger1, Jan Wenzel, Roman Bogdan, Doreen Richardt, Filomain Nguemo, Michael Reppel, Jürgen Hescheler, Heinrich Terlau, Andreas Dendorfer.   

Abstract

AIMS: Cardiovascular research requires complex and functionally intact experimental models. Due to major differences in the cellular and subcellular composition of the myocardium between species, the use of human heart tissue is highly desirable. To enhance the experimental use of the human myocardium, we established methods for the preparation of vital tissue slices from the adult ventricular myocardium as well as conditions for their long-term preservation in organotypic culture. METHODS AND
RESULTS: Human ventricular heart samples were derived from surgical specimens excised during a therapeutic Morrow myectomy and cut into 300 μm thick slices. Slices were either characterized in acute experiments or cultured at a liquid-air interface. Viability and functionality were proven by viability staining, enzyme activity tests, intracellular potential recordings, and force measurements. Precision-cut slices showed high viability throughout 28 days in culture and displayed typical cardiomyocyte action potential characteristics, which enabled pharmacological safety testing on the rapid component of the delayed rectifier potassium current (I(Kr)) and ATP-dependent potassium channels throughout the whole culture period. Constant expression of major ion channels was confirmed by quantitative PCR. Acute slices developed excitation-dependent contractions with a clear preload dependency and a β-adrenergic response. Contractility and myosin light chain expression decreased during the first days in culture but reached a steady state with reactivity upon β-adrenergic stimulation being preserved.
CONCLUSION: Organotypic heart slices represent a multicellular model of the human myocardium and a novel platform for studies ranging from the investigation of molecular interactions to tissue engineering.

Entities:  

Mesh:

Year:  2011        PMID: 21972180     DOI: 10.1093/cvr/cvr259

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  47 in total

Review 1.  Engineered heart tissues and induced pluripotent stem cells: Macro- and microstructures for disease modeling, drug screening, and translational studies.

Authors:  Evangeline Tzatzalos; Oscar J Abilez; Praveen Shukla; Joseph C Wu
Journal:  Adv Drug Deliv Rev       Date:  2015-09-30       Impact factor: 15.470

Review 2.  Maturing human pluripotent stem cell-derived cardiomyocytes in human engineered cardiac tissues.

Authors:  Nicole T Feric; Milica Radisic
Journal:  Adv Drug Deliv Rev       Date:  2015-05-05       Impact factor: 15.470

3.  Neuregulin stimulation of cardiomyocyte regeneration in mice and human myocardium reveals a therapeutic window.

Authors:  Brian D Polizzotti; Balakrishnan Ganapathy; Stuart Walsh; Sangita Choudhury; Niyatie Ammanamanchi; David G Bennett; Cristobal G dos Remedios; Bernhard J Haubner; Josef M Penninger; Bernhard Kühn
Journal:  Sci Transl Med       Date:  2015-04-01       Impact factor: 17.956

4.  A novel ex vivo culture method for the embryonic mouse heart.

Authors:  Laura A Dyer; Cam Patterson
Journal:  J Vis Exp       Date:  2013-05-24       Impact factor: 1.355

5.  Passive Stretch Induces Structural and Functional Maturation of Engineered Heart Muscle as Predicted by Computational Modeling.

Authors:  Oscar J Abilez; Evangeline Tzatzalos; Huaxiao Yang; Ming-Tao Zhao; Gwanghyun Jung; Alexander M Zöllner; Malte Tiburcy; Johannes Riegler; Elena Matsa; Praveen Shukla; Yan Zhuge; Tony Chour; Vincent C Chen; Paul W Burridge; Ioannis Karakikes; Ellen Kuhl; Daniel Bernstein; Larry A Couture; Joseph D Gold; Wolfram H Zimmermann; Joseph C Wu
Journal:  Stem Cells       Date:  2017-11-13       Impact factor: 6.277

Review 6.  Finding the rhythm of sudden cardiac death: new opportunities using induced pluripotent stem cell-derived cardiomyocytes.

Authors:  Karim Sallam; Yingxin Li; Philip T Sager; Steven R Houser; Joseph C Wu
Journal:  Circ Res       Date:  2015-06-05       Impact factor: 17.367

Review 7.  Cross talk between cardiac myocytes and fibroblasts: from multiscale investigative approaches to mechanisms and functional consequences.

Authors:  P Zhang; J Su; U Mende
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-10-12       Impact factor: 4.733

8.  Explant culture of adult zebrafish hearts for epicardial regeneration studies.

Authors:  Jingli Cao; Kenneth D Poss
Journal:  Nat Protoc       Date:  2016-04-07       Impact factor: 13.491

9.  Human ex-vivo action potential model for pro-arrhythmia risk assessment.

Authors:  Guy Page; Phachareeya Ratchada; Yannick Miron; Guido Steiner; Andre Ghetti; Paul E Miller; Jack A Reynolds; Ken Wang; Andrea Greiter-Wilke; Liudmila Polonchuk; Martin Traebert; Gary A Gintant; Najah Abi-Gerges
Journal:  J Pharmacol Toxicol Methods       Date:  2016-05-25       Impact factor: 1.950

10.  Minimally invasive system to reliably characterize ventricular electrophysiology from living donors.

Authors:  Aida Oliván-Viguera; María Pérez-Zabalza; Laura García-Mendívil; Konstantinos A Mountris; Sofía Orós-Rodrigo; Estel Ramos-Marquès; José María Vallejo-Gil; Pedro Carlos Fresneda-Roldán; Javier Fañanás-Mastral; Manuel Vázquez-Sancho; Marta Matamala-Adell; Fernando Sorribas-Berjón; Javier André Bellido-Morales; Francisco Javier Mancebón-Sierra; Alexánder Sebastián Vaca-Núñez; Carlos Ballester-Cuenca; Miguel Ángel Marigil; Cristina Pastor; Laura Ordovás; Ralf Köhler; Emiliano Diez; Esther Pueyo
Journal:  Sci Rep       Date:  2020-11-17       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.